Phiogen

Private

Houston, TexasHealthcare & Life Scienceshttps://phiogen.com/

Last Round

Grant

Aug 26, 2025

Total Funding Raised

$1.1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Phiogen is a biotechnology company that develops a platform to generate next-generation therapeutics utilizing bacteriophages for broad patient applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

bacteriophage therapeuticsphage therapyantimicrobial resistanceAMRdrug-resistant infectionssuperbugsphage discovery platformoff-the-shelf therapeuticsantibiotic alternativespreclinical biotechnologyrecurrent urinary tract infectionsrUTIsdirected evolutionbloodstream infectionsbacteremiadrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phiogen Comps

Public and private peers based on sector, stage, and business model.

Phiogen comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Phiogen Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Aug 26, 2025
Accelerator	Sep 11, 2024
Seed	Jan 1, 2023
Accelerator	Jan 28, 2022

View all Funding Rounds

Phiogen Investors

Notable investors and investment history

Phiogen investors
Investor	Rounds
CARB-X	Grant
INCATE	Accelerator
Springboard Enterprises	Accelerator
BCM Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Aug 26, 2025
$1.1M grant awarded by CARB-X.
Sep 11, 2024
Participated in an accelerator round with Springboard Enterprises.

View all signals

Phiogen Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Phiogen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Phiogen's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas

Year Founded2023

Last FundingAug 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.